3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Neoplasms
1
Glioma
1
Glioblastoma
1
Brain Neoplasms
1
Astrocytoma
1
Interventions
Radiotherapy
8
Temozolomide
7
Lomustine
6
Procarbazine
4
Carmustine
4
Bevacizumab
4
Vincristine
3
Surgical Procedures, Operative
2
Administration, Oral
2
vorasidenib
1
fluorodopa F 18
1
contrast agent BR1
1
carmustine, poliferprosan 20 drug combination
1
Valproic Acid
1
Tranexamic Acid
1
Trabedersen
1
TIC10 compound
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiation
1
Microbubbles
1
Methylphenidate
1
Methods
1
Isotretinoin
1
Infusions, Intravenous
1
IL13-PE38
1
Fentanyl
1
Eflornithine
1
Drug Delivery Systems
1
Donepezil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Glioma
×
Trabedersen
×
Clear all
NCT00761280
2014-11-14
SAPPHIRE
Isarna Therapeutics GmbH
Phase 3
Terminated
27 enrolled
28 charts